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Purpose

Methods

Implications for Practice

The purpose of this quality improvement study is to compare the rate
of depression screening, treatment, and referral to behavioral health
in adult patients with DM2 pre- and post- integration of depression
screening tools into the electronic health record (EHR).

● Study Design
Retrospective Chart Review

● This quality improvement study shows that there is no diﬀerence

Specific Aims
● Determine whether

depression screening in the
EHR has increased
depression screening,
treatment, and/or referral to
behavior team by at least
60% in 6 months after
integration.
● Compare the data before
integration and after
integration using descriptive
statistics.
● Develop an eﬃcient way to
improve consistent
depression screening.

● Setting
University of Tennessee Family Medicine Primary Care Clinic
● Study Duration
Period of enrollment or chart review covers those from the year 2017 or
prior for before integration data and 2020 to present for after integration.
● Study Population
Inclusion criteria: Adult patients with diabetes (18 years of age and
above) with no initial diagnosis of depression or other mental illnesses.
Exclusion criteria: Younger than the study population (<18 years of age)
with previous diagnosis of depression or mental illness prior to diabetes
diagnosis and taking any antidepressants or antipsychotic agents.
Comparison group: Study population of the same characteristics from
the same clinic before integration.
● Endpoints
Screened with PHQ2; if positive, screened with PHQ9, started on
antidepressants, and/or referral to behavior team.

in the rate of depression screening, treatment, and referral to
behavioral health in adult patients with DM2 pre- and postintegration of depression screening tools into the EHR.
● This suggests providers are good in screening DM2 patients for
depression whether the screening tools were incorporated in the
EHR or not.
● For consistent depression screening and reliability of
documentation, future studies with regard to provider-support
staﬀ and patient convenience relating to accessibility and
availability of the tool should be conducted.
● Ease of charting, hours of work to scan documents into the EHR,
risk of patient information getting lost, and the use of paper that
requires shredding to comply with privacy should also be taken
into account.

Results

Background
• Diabetes mellitus and depression are important comorbid
conditions that can lead to more serious health outcomes
(Otienoet et al., 2017).
• The American Diabetes Association (ADA) supports routine
screening for depression as part of standard diabetes
management (ADA, 2017). Early detection and treatment of
depression leads to better health care outcomes, e.g., medication
and dietary compliance, less comorbidities, and decrease in health
care costs.
• The PHQ-2 screen found comparable performance with other
instruments and also a good diagnostic performance in screening
for major depressive disorder (Tsoiet et al., 2017). In a systematic
review and meta-analysis study, de Joodeet et al. (2019) evaluated
the diagnostic accuracy of depression questionnaires in adults
with type 1 or type 2 diabetes and found that PHQ-9 had the
highest specificity.
• A study by Joseph et al. (2018) confirmed that routine screening
for depression in patients with diabetes hospitalized with a
medical illness is easy and feasible.
• Despite evidence-based recommendations, routine depression
screening and management are not always included in the
management of patients with diabetes (Joseph et al., 2018), thus
highlighting the importance and necessity of this study.

References

● All subjects (100%) were screened using PHQ-2 before integration and

after integration. Twenty percent of patients screened had a positive PHQ2
among subjects before integration, while 10% had a positive PHQ2 after
integration. Twenty percent of patients were screened with a PHQ9 preintegration that accounted for 100% of those subjects with a positive
PHQ2.
● There were no referrals made to the behavior team in both groups.
● However, of the 10% of patients with a positive PHQ2 post-integration,
only 6.7% of subjects were screened, which means not all patients with a
positive PHQ2 were adequately screened post-integration. Interestingly,
10% of patients were treated with antidepressants before integration,
while none were treated with medications in the post-integration group.

American Diabetes Association (2017). Standards of Medical Care in Diabetes-2017. Diabetes Care,40
(Suppl. 1), S1–S135.
de Joode, J., van Dijk, S.,Walburg, F.,Bosmans, J., van Marwijk, H., de Boer, M.,vanTulder, M., &
Adriaanse, M. (2019). Diagnostic accuracy of depression questionnaires in adult patients with
diabetes: A systematic review and meta-analysis. PloSOne, 14(6), e0218512.
https://doi.org/10.1371/journal.pone.0218512
Golden, S., Shah, N., Naqibuddin, M., Payne, J., Hill-Briggs, F., Wand, G.,Langan, S., & Lyketsos, C.
(2017). The Prevalence and Specificity of Depression Diagnosis in a Clinic-Based Population of
Adults With Type 2 Diabetes Mellitus. Psychosomatics, 58(1), 28–37.
https://doi.org/10.1016/j.psym.2016.08.003
Joseph, L., Berry, D., Jessup, A., Davison, J., J Schneider, B., & I Twersky, J. (2019). Implementing and
feasibility testing depression screening using the electronic medical record for patients with type 2
diabetes admitted to the hospital. Nursing Open, 6(1), 30–38. https://doi.org/10.1002/nop2.181
Kearns, B., Rafia, R.,Leaviss, J., Preston, L., Brazier, J. E., Palmer, S., & Ara, R. (2017). The costeﬀectiveness of changes to the care pathway used to identify depression and provide treatment
amongst people with diabetes in England: a model-based economic evaluation. BMC Health
Services Research, 17(1), 78. https://doi:10.1186/s12913-017-2003-z
Pálinkás, A.,Sándor, J., Papp, M., Kőrösi, L.,Falusi, Z.,Pál, L.,Zsuzsanna, B.,Rihmer, Z., & Döme, P.
(2019). Associations between untreated depression and secondary health care utilization in
patients with hypertension and/or diabetes. Social Psychiatry and Psychiatric Epidemiology, 54(2),
255–276. https://doi.org/10.1007/s00127-018-1545-7
Tsoi, K., Chan, J., Hirai, H., & Wong, S. (2017). Comparison of diagnostic performance of Two-Question
Screen and 15 depression screening instruments for older adults: Systematic review and metaanalysis.The British Journal of Psychiatry, 210(4), 255–260
https://doi.org/10.1192/bjp.bp.116.186932

